Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
Supply shortages without end … how might we get out of this?

NEW ON THE MARKET
COVID-19 vaccine VIDPREVTYN BETA
Faricimab (VABYSMO) for wet macular degeneration and diabetic macular edema (short version)

a-t READERS QUESTIONS AND COMMENTS
Acetylsalicylic acid for the prevention of thromboembolism?
New data on fampridine (e.g. FAMPYRA)

IN BRIEF
REVLIMID (lenalidomide) 135 times more expensive than generics
Withdrawal of accelerated approvals in the USA – atezolizumab (TECENTRIQ) for urothelial carcinoma

SIDE EFFECTS
Finasteride (PROPECIA, generics): additional warning in France  free article 

e a-t ON THE INTERNET
Supply shortages of brand-name drugs
Faricimab (VABYSMO) for wet macular degeneration and diabetic macular edema (long version)
© 2024 arznei-telegramm